Copy of Publication for Un-Audited Financial Results for the Quarter ended on 30.06.2022

We wish to inform you that the Board of Directors of the Company at its meeting held today approved the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on June 30, 2022.

Shivalik Rasayan Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 ,inter alia, to consider and approve Un-audited financial results (Standalone & Consolidated) for quarter ended on June 30, 2022

Marketing Agreement with CHINA CHINOPHARMA LTD (CSC)

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Parul ChoudharyDesignation :- Company Secretary and Compliance Officer

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2022

In pursuance of the Company's Code of Conduct for prevention of Insider Trading in terms of SEBI (Prohibition of Insider Trading) Regulations and Code of Practices and Procedure for fair disclosure of Unpublished Price Sensitive Information, the trading window will be closed for the Directors, Designated Employees of the Company, other specified persons and Insiders from July 1, 2022 till the declaration of the Un-audited Financial Results of the Company for the quarter ending on June 30, 2022 and the two days thereafter.

Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Copy of Publication for Audited Financial Results for the Quarter and Year ended on 31.03.2022

Annual Secretarial Compliance Report for the year ended March 31, 2022